The molecular diagnostic manufacturer and testing company Rosetta Genomics (Philadelphia; Rehovot, Israel) has sold Parkway Clinical Laboratories (Bensalem, Pa.) in a management buy-out agreement for $2.5 million, to be paid out as a fixed percentage of revenues over six years. The chairman of the company will be Raza Bokhari, M.D., and the president will be Masood Haider, Ph.D., according to a Rosetta spokeswoman.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2009 - Table of Contents

LIR June 2009 (full PDF issue)

G-2 Reports March Survey Finds Test Volume Growth Slows to Less Than 1% During First Quarter; Lab Directors Expect 1.4% Growth for 2009

H1N1 Pandemic Threat, Health Care Overhaul Underscore Key National Priorities for Labs

CAP, ASCP Join ACLU Suit Over Breast Cancer Gene Patents

CMS Denies Reimbursement for Gene-Based Warfarin Testing; Proposes Clinical Trial Coverage

Medicare Part B Lab Spending Up 3.3% to $7.3 Billion in 2008

Inside the Lab Industry: CDC Limits Lab Industry’s Role in H1N1 Flu Diagnosis Due to IP, Reagent Supply Concerns

PLUS Diagnostics Opens West Coast Lab; Plans to Launch Hematology/Oncology Testing Services This Year

Rosetta Genomics Sells Parkway Clinical Labs for $2.5 Million in Management Buy-Out

Lab Stocks Continue to Gather Strength; Up 3% Over Five Weeks, 10% for 2009

Industry Buzz: OIG Finds Improper Medicaid Spending on Lab Services